HD Biosciences
Acquired- Headquarters
- Shanghai
- Employees
- 51–200
- Business Model
- B2B
- Website
- hdbiosciences.com
About
HD Biosciences (HDB) is a biology-focused preclinical drug discovery contract research organization (CRO) with headquarters in Shanghai, China, and US operations in San Diego, California and New Jersey. The company offers comprehensive service platforms covering target validation, assay development, high-throughput screening (HTS), lead optimization, and ADME/toxicology to support pharma and biotech clients across early-stage drug discovery. HD Biosciences specializes in plate-based assay development and has particular expertise in mitochondrial toxicity and metabolism assays. The company was acquired by WuXi AppTec in May 2017 and operates as a WuXi AppTec subsidiary.
Summary
HD Biosciences is a Biotech company based in Shanghai, China.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hd-biosciences"><img src="https://indexed.vc/api/badge/company/hd-biosciences" alt="HD Biosciences on Indexed.vc" width="260" height="76" /></a>